Enterprise record

Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:e1bb5dfa-7ed9-492b-b9ec-7324c58de716Version: public-1As of: unavailable

14 published Claims4 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 29, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

4 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 29, 2026

    Supports 3 claims
    • Legal Name: Pelthos Therapeutics Inc. · Claim reviewed: Sep 29, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 29, 2026
    • Published Fact: US · Claim reviewed: Sep 29, 2026

  2. SEC DEF 14A 0001919246-26-000120

    sec def 14a · Source published: Aug 18, 2026 · Retrieved: Sep 12, 2026

    Supports 5 claims
    • Leadership Role: Peter Greenleaf: Chairman of the Board · Claim reviewed: Sep 29, 2026
    • Leadership Role: Scott Plesha: Director, Chief Executive Officer and President · Claim reviewed: Sep 29, 2026
    • Leadership Role: John M. Gay: Chief Financial Officer, Secretary and Treasurer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Sai Rangarao: Chief Commercial Officer · Claim reviewed: Sep 29, 2026
    • Leadership Role: Scott Plesha: Chief Executive Officer and President · Claim reviewed: Sep 29, 2026

  3. DEF 14A pths-20260818.htm

    sec proxy · Source published: Aug 18, 2026 · Retrieved: Sep 2, 2026

    Supports 5 claims
    • Leadership Role: Andrew Einhorn: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Ezra Friedberg: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Matthew Pauls: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Richard Baxter: Director · Claim reviewed: Sep 29, 2026
    • Leadership Role: Todd Davis: Director · Claim reviewed: Sep 29, 2026

  4. PTHS 10-K executive officers

    sec filing · Source published: Mar 19, 2026 · Retrieved: May 16, 2026

    Supports 1 claim
    • Leadership Role: Francis Knuettel II: Chief Financial Officer, Treasurer and Secretary · Claim reviewed: Sep 29, 2026